Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
about
Atypical antipsychotics for disruptive behaviour disorders in children and youthsAntiepileptics for aggression and associated impulsivityContemporary assessment and pharmacotherapy of Tourette syndromePharmacotherapy of aggression in children and adolescents: efficacy and effect sizeComorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-aDisruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youthCanadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorderReward processing in autism: a thematic series.Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders.Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Neuropsychiatry of aggression.Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHDPharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behaviorTreatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation DisorderMarijuana withdrawal in humans: effects of oral THC or divalproex.Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.Emotion dysregulation in attention deficit hyperactivity disorderValproate.The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorderMedication strategies in childhood aggression: a review.The treatment of severe child aggression (TOSCA) study: Design challenges.Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders.Divalproex sodium in the treatment of pediatric psychiatric disorders.Aggression and disruptive behavior disorders in children and adolescents.Neural Mechanisms of Cognitive-Behavioral Therapy for Aggression in Children and Adolescents: Design of a Randomized Controlled Trial Within the National Institute for Mental Health Research Domain Criteria Construct of Frustrative Non-Reward.Spectrum of effectiveness of valproate in neuropsychiatry.Pharmacological treatment of pathologic aggression in children.Use of dronabinol for cannabis dependence: two case reports and review.Comorbidity in pediatric bipolar disorderRecommendations for pharmacological management of inpatient aggression in children and adolescents.Pharmacological management of acute and persistent aggression in forensic psychiatry settings.The appropriateness of treating psychopathic disorders.Atypical antipsychotics for disruptive behaviour disorders in children and youths.Pharmacotherapy of conduct disorder: Challenges, options and future directions.Transcriptome analysis of genes and gene networks involved in aggressive behavior in mouse and zebrafish.The treatment of bipolar patients with elevated impulsivity and suicide risk.
P2860
Q24200361-32E7A102-1A7F-406E-81A8-A29D45AF5DC4Q24239975-29D1AE41-EB38-4652-96C0-C1E825DAB709Q24607941-5AF67D8D-A2D5-4F9B-A363-AFF8ED75BB74Q24648097-9440C9B6-3C68-4599-8949-711957B5B594Q24810652-B556FB12-16B2-4515-9E51-EF4BD7A859ECQ26849779-1C25A6A5-154C-44B8-85BC-547D8907AC41Q27009447-D6B612D4-04C2-4416-B885-CE3B45C396D7Q28260681-35CDE642-CE25-4F66-BD60-FA3DAF0519E4Q30462673-327133A5-0076-4D86-AF4B-FEE91D820FF6Q33411020-2624E1A2-4B61-4A2C-9CA1-3E12FEFA2EF5Q33664736-89D1F115-E7FF-4021-B89B-161D01B7B13AQ34131298-F8CB6A78-4B5B-42E9-909C-CF35ABCCFAF5Q34152823-097FBC60-3658-4E3E-993C-EF7EB7048844Q34155826-AE467C19-60F4-4DCC-BC21-31A42EDF0B50Q34205490-1BF9632C-8A70-4045-AA4F-17B907B860B1Q34205524-0A35BBBE-A11B-4E41-BEF4-BE19E808F390Q34492314-6F9CA3B3-ED81-4A0A-8508-5EC8F54400FAQ34542579-6769843D-3ABD-44A5-8DBD-567AA07EACE3Q34589479-B25B22D9-676B-4544-B0C0-13C5DF280603Q34803697-6EDB65EA-C1A7-46A8-B3CB-EE94908EFE4EQ35142736-8263DF47-E451-47B6-BE29-135A05087E8EQ35160280-9E625EF3-99D2-4AB6-B604-7152AA596322Q35190427-879FD4F0-C518-4006-B5E0-68E2EFE83FF0Q35595839-73BD5F2F-49A5-4E79-B807-B228BEA7C66EQ35625906-F71F81EA-EB0D-4FC0-A6CD-159710D8F975Q35939596-24D9843C-69AF-4945-B457-1FA2AF4308B2Q36106793-E2E2FA7F-D636-4C01-B907-20F844852D99Q36107152-C6923961-60C8-4F94-92A5-8F7A59C48E72Q36654452-F7EC2E4C-399A-469E-A75B-4663FD898B27Q36691749-2A39741C-D250-4999-B8E2-8E77BDAFBBB7Q37127437-12C6E9E7-B370-4C34-8C7A-245A6FDBAAD2Q37130288-0C519AFF-A71B-4388-9032-5F3B076DDEDDQ37134087-FE67466D-DE54-4A73-9994-69BDBFE871D5Q37726988-F2374AE9-AA31-4A70-95F3-C1B079DD0D12Q37963568-21166AE1-829C-4134-80D5-B517438780C0Q38439581-344D800A-2FAE-4F30-9E06-1BB334072C99Q38632745-F19C5FC1-EF9D-4869-A6D2-C70EF4F26603Q38839950-13BF2665-051F-4950-A3E3-2623C3526C2FQ39208385-8C522AB3-A1D3-43F0-A782-CC43C71E537BQ41431544-29C8BF18-C960-4A32-8193-9E2698F228F9
P2860
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Divalproex treatment for youth ...... o-controlled crossover design.
@ast
Divalproex treatment for youth ...... o-controlled crossover design.
@en
type
label
Divalproex treatment for youth ...... o-controlled crossover design.
@ast
Divalproex treatment for youth ...... o-controlled crossover design.
@en
prefLabel
Divalproex treatment for youth ...... o-controlled crossover design.
@ast
Divalproex treatment for youth ...... o-controlled crossover design.
@en
P2093
P1476
Divalproex treatment for youth ...... o-controlled crossover design.
@en
P2093
Donovan SJ
Quitkin FM
Stewart JW
P304
P356
10.1176/APPI.AJP.157.5.818
P407
P577
2000-05-01T00:00:00Z